Nationwide recall of Xanax due to possible 'foreign substance'

Share

There are concerns about the cost of prescriptions as President Trump is set to unveil his own health care plan.

In a press release issued on Friday, Mylan said "this lot is being recalled due tothe potential presence of foreign substance".

Mylan Pharmaceuticals said in the recall notice that there could be a chance of infection in the Alprazolam pills, which is sold by the brand name Xanax.

Alprazolam is used to manage anxiety disorder, provide short-term relief for anxiety symptoms and treat panic disorder, according to the FDA.

More news: Automakers swerve, side with Trump against California lawsuit
More news: Hazard Speaks On Career At Madrid
More news: Manchester City vs. Southampton - Football Match Report

The one lot being recalled was distributed in the United States between July 2019 and August 2019, according to Mylan.

Mylan also says any adverse reactions a person has experienced after taking alprazolam should be reported to FDA's MedWatch Adverse Event Reporting program, which you can do online or call 1- 800-332-1088 to get a paper form. The bottles have a September 2020 expiration date and were distributed across the US between July and August, officials said.

"The recall is specific to one lot distributed in the US", said Lauren Kashtan in an email.

Share